- National Guidance for Lipid Optimisation in the Primary and Secondary Prevention of CVD Nov 24
- Ivabradine in POTS patient information leaflet
- Midodrine Amber G Guidance
- Sacubitril Valsartan AMBER-G guidance
- Lipid optimisation for the Secondary Prevention of Cardiovascular Disease in Adults (updated April 2024)
- Pathway for Bempedoic Acid use in hyperlipidaemia
- FH Lipid pathway
- Riluzole